[Bacteriology and biotherapy of peritonsillar abscess after resistance testing of the causative agent].
D000038:Abscess; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D001432:Bacteriology; D001691:Biological Therapy; D003879:Dermatologic Agents; D006801:Humans; D014066:Palatine Tonsil; D000039:Peritonsillar Abscess; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
ABSCESS; ANTIBIOTICS/therapeutic use; SULFONAMIDES/therapeutic use; TONSILS/abscess
Zur Bakteriologie und Biotherapie des Peritonsillarabszesses nach Resistenzprüfung der Erreger.